Who to call at Genethon, and when
Fundz watches for the moments Genethon starts buying, and tells you who to reach.
- An alert the day Genethon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genethon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genethon. With Fundz connected, it knows.
Genethon and Hansa Biopharma Launch Trial for Gene Therapy and Antibody Cleaving Enzyme Therapy Combination Treatment
Contract Type
partnership
RomeBiotechnologyHealth CareGeneticsTherapeuticsDescription
Genethon and Hansa Biopharma have partnered to initiate a phase 2 clinical trial for a combination treatment of gene therapy and antibody cleaving enzyme therapy in Crigler-Najjar syndrome, aimed at addressing the challenge of preexisting antibodies inhibiting the activity of gene therapies.
Quick answer
Genethon and Hansa Biopharma Launch Trial for Gene Therapy and Antibody Cleaving Enzyme Therapy Combination Treatment (December 3, 2024). Genethon is based in Rome, Lazio, Italy.
- What agreement did Genethon announce on December 3, 2024?
- Genethon and Hansa Biopharma have partnered to initiate a phase 2 clinical trial for a combination treatment of gene therapy and antibody cleaving enzyme therapy in Crigler-Najjar syndrome, aimed at addressing the challenge of preexisting antibodies inhibiting the activity of gene therapies.
- What does Genethon do?
- Généthon is a pioneer in the discovery and development of gene therapies for rare diseases, established by the AFM-Téléthon.
- Where is Genethon based?
- Genethon is based in Rome, Lazio, Italy.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansGenethon signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.